Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Pursuant to Department Order 345‐Is of the Department of Health (DOH) and jointly supported by the Australian Agency for International Development, the National Adverse Drug Reaction Advisory Committee (NADRAC) was created in 1994. It was established to assist the Philippine Food and Drug Administration (FDA), then known as the Bureau of Food and Drugs, in matters related to ADRs monitoring. In addition to online drug alerts and through the media, the National Pharmacovigilance Center (NPC)‐FDA also releases Signals ‐ a twice yearly ADR newsletter. In 2010, a series of training on pharmacovigilance was provided by the FDA to equip health workers in the recognition, monitoring, reporting and management of ADRs specifically in government hospitals. This aims to improve the low reporting rates observed from health care professionals relative to the 93 261000 population of the country.